The clinical immunology of human Chagas disease

Walderez O Dutra1, Manoel Otávio C Rocha, Mauro M Teixeira

  • 1Department of Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, Minas Gerais 31270-901, Brazil.

Trends in Parasitology
|October 21, 2005
PubMed

Insights

This review details the immunology of human Chagas disease, caused by Trypanosoma cruzi. It highlights the wide range of clinical symptoms and the need for standardized criteria in research.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Parasitology

Background:

  • Chagas disease affects 17 million people in Latin America, caused by Trypanosoma cruzi.
  • A significant portion of infected individuals develop clinical symptoms or abnormal test results.
  • Clinical manifestations vary widely, from asymptomatic cases to severe cardiac issues.

Purpose of the Study:

  • To conduct a systematic review of human Chagas disease immunology.
  • To discuss recent immunological findings within a clinical context.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of immunological data in human Chagas disease.

Main Results:

  • The study synthesizes current knowledge on the immune response in Chagas disease.
  • It emphasizes the correlation between immunological profiles and clinical outcomes.
  • The review underscores the variability in disease presentation.

Conclusions:

  • Standardized clinical criteria are essential for consistent research across different groups.
  • Understanding Chagas disease immunology is crucial for managing its diverse clinical spectrum.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.